Viridian Therapeutics Inc
F:1S1
Viridian Therapeutics Inc
F:1S1
Price:
11.3
EUR
0.89%
Market Cap:
€721.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Viridian Therapeutics Inc
F:1S1
|
US |
|
I
|
ImmunoGen Inc
XBER:IMU
|
US |
|
P
|
Progressive Corp
DUS:PGV
|
US |
|
Compass Group PLC
LSE:CPG
|
UK |
|
E
|
Equifax Inc
DUS:EFX
|
US |
|
A
|
Antofagasta PLC
F:FG1
|
UK |
|
F
|
First Advantage Corp
XBER:0MS
|
US |
|
A
|
AP Moeller - Maersk A/S
F:DP4A
|
DK |
|
S
|
Skyworks Solutions Inc
F:AWM
|
US |
|
S
|
SUESS MicroTec SE
XMUN:SMHN
|
DE |
|
Soleno Therapeutics Inc
F:6XC
|
US |
|
F
|
Fastenal Co
XMUN:FAS
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Viridian Therapeutics Inc (1S1) under the Base Case is hidden
EUR.
Compared with the current market price of 11.3 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
1S1 Multiples-Based Value
LOCKED
